These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27457221)

  • 1. Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35.
    Chow EK; Massie AB; Luo X; Wickliffe CE; Gentry SE; Cameron AM; Segev DL
    Am J Transplant; 2017 Feb; 17(2):512-518. PubMed ID: 27457221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Body Surface Area With Access to Deceased Donor Liver Transplant and Novel Allocation Policies.
    Kling CE; Biggins SW; Bambha KM; Feld LD; Perkins JH; Reyes JD; Perkins JD
    JAMA Surg; 2023 Jun; 158(6):610-616. PubMed ID: 36988928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MELD is MELD is MELD? Transplant center-level variation in waitlist mortality for candidates with the same biological MELD.
    Ishaque T; Kernodle AB; Motter JD; Jackson KR; Chiang TP; Getsin S; Boyarsky BJ; Garonzik-Wang J; Gentry SE; Segev DL; Massie AB
    Am J Transplant; 2021 Oct; 21(10):3305-3311. PubMed ID: 33870635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of Share 35 on the cost of liver transplantation.
    Berumen J; Misel M; Vodkin I; Halldorson JB; Mekeel KL; Hemming A
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28235131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
    Malamon JS; Kaplan B; Jackson WE; Saben JL; Schold JD; Pomfret EA; Pomposelli JJ
    Int J Surg; 2023 Sep; 109(9):2714-2720. PubMed ID: 37226874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study.
    Lee J; Lee JG; Jung I; Joo DJ; Kim SI; Kim MS;
    Sci Rep; 2019 May; 9(1):7495. PubMed ID: 31097768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Transplant Waitlist Outcomes and the Allocation of Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception Points at a Low-Volume Center.
    Tan EK; Goh BKP; Lee SY; Krishnamoorthy TL; Tan CK; Jeyaraj PR
    Transplant Proc; 2018 Dec; 50(10):3564-3570. PubMed ID: 30577239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory Death.
    Miyake K; Chau LC; Trudeau S; Kitajima T; Wickramaratne N; Shimada S; Nassar A; Gonzalez HC; Venkat D; Moonka D; Yoshida A; Abouljoud MS; Nagai S
    Transplantation; 2024 Sep; 108(9):1943-1953. PubMed ID: 38409687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One Size Does Not Fit All--Regional Variation in the Impact of the Share 35 Liver Allocation Policy.
    Halazun KJ; Mathur AK; Rana AA; Massie AB; Mohan S; Patzer RE; Wedd JP; Samstein B; Subramanian RM; Campos BD; Knechtle SJ
    Am J Transplant; 2016 Jan; 16(1):137-42. PubMed ID: 26561981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
    Hsu EK; Shaffer ML; Gao L; Sonnenday C; Volk ML; Bucuvalas J; Lai JC
    Gastroenterology; 2017 Oct; 153(4):988-995. PubMed ID: 28711630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELD as a metric for survival benefit of liver transplantation.
    Luo X; Leanza J; Massie AB; Garonzik-Wang JM; Haugen CE; Gentry SE; Ottmann SE; Segev DL
    Am J Transplant; 2018 May; 18(5):1231-1237. PubMed ID: 29316310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
    Nagai S; Chau LC; Kitajima T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
    Am J Transplant; 2020 Aug; 20(8):2184-2197. PubMed ID: 32155314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End-Stage Liver Disease Patients.
    Ross K; Patzer RE; Goldberg DS; Lynch RJ
    Am J Transplant; 2017 Nov; 17(11):2879-2889. PubMed ID: 28695615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCC patients suffer less from geographic differences in organ availability.
    Schuetz C; Dong N; Smoot E; Elias N; Schoenfeld DA; Markmann JF; Yeh H
    Am J Transplant; 2013 Nov; 13(11):2989-95. PubMed ID: 24011291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit of accepting livers from deceased donors over 70 years old.
    Haugen CE; Bowring MG; Holscher CM; Jackson KR; Garonzik-Wang J; Cameron AM; Philosophe B; McAdams-DeMarco M; Segev DL
    Am J Transplant; 2019 Jul; 19(7):2020-2028. PubMed ID: 30614634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40.
    Kim WR; Mannalithara A; Kwo PY; Bonham CA; Kwong A
    Hepatology; 2023 Mar; 77(3):851-861. PubMed ID: 36052665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation and waitlist mortality for HCC and non-HCC candidates following the 2015 HCC exception policy change.
    Ishaque T; Massie AB; Bowring MG; Haugen CE; Ruck JM; Halpern SE; Waldram MM; Henderson ML; Garonzik Wang JM; Cameron AM; Philosophe B; Ottmann S; Rositch AF; Segev DL
    Am J Transplant; 2019 Feb; 19(2):564-572. PubMed ID: 30312530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.